Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Serum epidermal growth factor-like domain 7 serves as a novel diagnostic marker for early hepatocellular carcinoma

Fig. 1

Serum Egfl7 and AFP levels in the Testing Cohort. Serum Egfl7 (A) and AFP (B) levels in patients from the Testing Cohort with early HCC (n = 314), metastatic liver cancer (n = 16), benign liver tumors (n = 19), chronic liver disease (n = 300), and healthy individuals (n = 432) were determined by ELISA. The horizontal lines in the figures represented means

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us